Literature DB >> 32363672

Enzyme-Triggered Disassembly of Perylene Monoimide-based Nanoclusters for Activatable and Deep Photodynamic Therapy.

Yang Cai1, Dongqi Ni2, Wenyu Cheng1, Chendong Ji1, Yaling Wang2, Klaus Müllen3, Zhiqiang Su1, Ying Liu2, Chunying Chen2, Meizhen Yin1.   

Abstract

Photodynamic therapy (PDT) exhibits great potential for cancer therapy, but still suffers from nonspecific photosensitivity and poor penetration of photosensitizer. Herein, a smart perylene monoimide-based nanocluster capable of enzyme-triggered disassembly is reported as an activatable and deeply penetrable photosensitizer. A novel carboxylesterase (CE)-responsive tetrachloroperylene monoimide (P1) was synthesized and assembled with folate-decorated albumins into a nanocluster (FHP) with a diameter of circa 100 nm. Once P1 is hydrolyzed by the tumor-specific CE, FHP disassembles into ultrasmall nanoparticles (ca. 10 nm), facilitating the deep tumor penetration of FHP. Furthermore, such enzyme-triggered disassembly of FHP leads to enhanced fluorescence intensity (ca. 8-fold) and elevated singlet oxygen generation ability (ca. 4-fold), enabling in situ near-infrared fluorescence imaging and promoted PDT. FHP permits remarkable tumor inhibition in vivo with minimal side effects through imaging-guided, activatable, and deep PDT. This work confirms that this cascaded multifunctional control through enzyme-triggered molecular disassembly is an effective strategy for precise cancer theranostics.
© 2020 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  NIR fluorescence imaging; activatable photodynamic therapy; deep tumor penetration; enzyme-triggered disassembly; perylene monoimide

Mesh:

Substances:

Year:  2020        PMID: 32363672     DOI: 10.1002/anie.202001107

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  8 in total

1.  Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical.

Authors:  Kun-Xu Teng; Li-Ya Niu; Nan Xie; Qing-Zheng Yang
Journal:  Nat Commun       Date:  2022-10-19       Impact factor: 17.694

2.  pH-responsive hybrid platelet membrane-coated nanobomb with deep tumor penetration ability and enhanced cancer thermal/chemodynamic therapy.

Authors:  Huang Yang; Yuan Ding; Zongrui Tong; Xiaohui Qian; Hao Xu; Fenghao Lin; Guoping Sheng; Liangjie Hong; Weilin Wang; Zhengwei Mao
Journal:  Theranostics       Date:  2022-05-16       Impact factor: 11.600

Review 3.  Activable Multi-Modal Nanoprobes for Imaging Diagnosis and Therapy of Tumors.

Authors:  Yan Yang; Saisai Yue; Yuanyuan Qiao; Peisen Zhang; Ni Jiang; Zhenbo Ning; Chunyan Liu; Yi Hou
Journal:  Front Chem       Date:  2021-04-12       Impact factor: 5.221

4.  Design of ZIF-based hybrid nanoparticles with hyaluronic acid-augmented ROS behavior for dual-modality PA/NIR-II FL imaging.

Authors:  Botao Qu; Yahong Han; Juan Li; Qian Wang; Bingyu Zhao; Xiaoyang Peng; Ruiping Zhang
Journal:  RSC Adv       Date:  2021-01-27       Impact factor: 3.361

5.  Albumin-mediated "Unlocking" of supramolecular prodrug-like nanozymes toward selective imaging-guided phototherapy.

Authors:  Jingjing Han; Haidong Li; Luyang Zhao; Gyoungmi Kim; Yahui Chen; Xuehai Yan; Juyoung Yoon
Journal:  Chem Sci       Date:  2022-06-06       Impact factor: 9.969

Review 6.  Functional Nanoparticles for Enhanced Cancer Therapy.

Authors:  Chenchen Li; Yuqing Li; Guangzhi Li; Song Wu
Journal:  Pharmaceutics       Date:  2022-08-12       Impact factor: 6.525

Review 7.  Recent Advances in the Enzyme-Activatable Organic Fluorescent Probes for Tumor Imaging and Therapy.

Authors:  Song-Bo Lu; Luyao Wei; Wenjing He; Zhen-Yu Bi; Yuhan Qian; Jinghan Wang; Hongqiu Lei; Kai Li
Journal:  ChemistryOpen       Date:  2022-10       Impact factor: 2.630

8.  An ultra-stable bio-inspired bacteriochlorin analogue for hypoxia-tolerant photodynamic therapy.

Authors:  Mengsi Wu; Zhiyong Liu; Weian Zhang
Journal:  Chem Sci       Date:  2020-11-26       Impact factor: 9.825

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.